Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review

Fig. 2

Optical coherence tomography and fluorescein angiography images obtained after the treatment of cystoid macular oedema (CMO). For the treatment, systemic acetazolamide resolved CMO in both eyes. After discontinuation of systemic acetazolamide due to deteriorating renal function, topical dorzolamide was used and resulted in aggravation of CMO. Intravitreal dexamethasone implant, used in the right eye, showed resolution of CMO at 1 month following the procedure. Fluorescein angiography images (E) obtained after the dexamethasone implant therapy revealed decreased leakage on the macula in the treated eye compared to the fellow eye

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us